tiprankstipranks
InnoCan Pharma (DE:IP4)
FRANKFURT:IP4

InnoCan Pharma (IP4) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
InnoCan Pharma’s (IP4) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting InnoCan Pharma is a Buy.
InnoCan Pharma’s (IP4) 20-Day exponential moving average is 0.19, while InnoCan Pharma’s (IP4) share price is €0.181, making it a Sell.
InnoCan Pharma’s (IP4) 50-Day exponential moving average is 0.20, while InnoCan Pharma’s (IP4) share price is €0.181, making it a Sell.

InnoCan Pharma (IP4) Pivot Points

Jun 16, 2024, 04:23 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.18
0.18
0.18
0.18
0.18
0.19
0.19
Fibonacci
0.18
0.18
0.18
0.18
0.18
0.18
0.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

InnoCan Pharma (IP4) Moving Averages

Jun 16, 2024, 04:23 PM
Period
Simple
Exponential
MA5
0.19Sell
0.19Sell
MA10
0.19Sell
0.19Sell
MA20
0.19Sell
0.19Sell
MA50
0.20Sell
0.20Sell
MA100
0.20Sell
0.20Sell
MA200
0.21Sell
0.20Sell
InnoCan Pharma’s (IP4) 10-Day exponential moving average is 0.19, while InnoCan Pharma’s (IP4) share price is €0.181, making it a Sell.
InnoCan Pharma’s (IP4) 100-Day exponential moving average is 0.20, while InnoCan Pharma’s (IP4) share price is €0.181, making it a Sell.
InnoCan Pharma’s (IP4) stock price is €0.181 and InnoCan Pharma’s (IP4) 50-day simple moving average is 0.20, creating a Sell signal.
InnoCan Pharma’s (IP4) stock price is €0.181 and InnoCan Pharma’s (IP4) 100-day simple moving average is 0.20, creating a Sell signal.
InnoCan Pharma’s (IP4) stock price is €0.181 and InnoCan Pharma’s (IP4) 200-day simple moving average is 0.21, creating a Sell signal.

InnoCan Pharma (IP4) Technical Indicators

Jun 16, 2024, 04:23 PM
Name
Value
Implied Action
RSI (14)
41.74
Neutral
STOCH (9,6)
30.00
Neutral
STOCHRSI (14)
17.51
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
10.35
Buy
Williams %R
-92.31
Buy
CCI (14)
-110.60
Buy
ATR (14)
<0.01
-
Ultimate Oscillator
44.86
Neutral
ROC
-9.50
Sell
InnoCan Pharma’s (IP4) Relative Strength Index (RSI) is 41.74, creating a Neutral signal.
InnoCan Pharma’s (IP4) Trend Strength Indicator (ADX) is 10.35, creating a Buy signal.
InnoCan Pharma’s (IP4) Commodity Channel Index (CCI) is -110.60, creating a Buy signal.
InnoCan Pharma’s (IP4) Price Rate of Change (ROC) is -9.50, creating a Sell signal.

FAQ

Is IP4 a Buy, Hold, or Sell?
Based on IP4’s technical indicators, IP4 is a Sell.
    What is IP4’s RSI (14)?
    IP4’s RSI (14) is 41.74, which suggests IP4 is a Neutral.
      What is IP4’s MACD?
      IP4’s MACD is >-0.01, which suggests IP4 is a Buy.
        What is IP4’s 5-day moving average?
        IP4’s 5-day moving average is 0.19, which suggests IP4 is a Sell.
          What is IP4’s 20-day moving average?
          IP4 20-day moving average is 0.19, which suggests IP4 is a Sell.
            What is IP4’s 50-day moving average?
            IP4’s 50-day moving average is 0.20, which suggests IP4 is a Sell.
              What is IP4’s 200-day moving average?
              IP4’s 200-day moving average is 0.21, which suggests IP4 is a Sell.
                What is IP4’s Williams % R (14)?
                IP4’s Williams % R (14) is -92.31, which suggests IP4 is a Buy.
                  What is IP4’s CCI (14)?
                  IP4’s CCI (14) is -110.60, which suggests IP4 is a Buy.
                    What is the share price of InnoCan Pharma?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis